Calendar Pacific Biosciences of California, Inc. Deutsche Boerse AG

Equities

P09

US69404D1081

Market Closed - Deutsche Boerse AG 03:54:31 2024-04-25 pm EDT 5-day change 1st Jan Change
1.266 EUR +1.07% Intraday chart for Pacific Biosciences of California, Inc. -8.29% -85.71%

Chart calendar Pacific Biosciences of California, Inc.

4fc.gjVZlomfKE7lJ9y6kIKK29u-gnof34Wsac5GDOyFQ5U.72VhwertfyypTrHK8_DftZnk6g9umO3WUbgCaKTxMfC0W2qi-cYYEbNsiQ~0604eddfd845ac4807677a6ef890db15

Upcoming events on Pacific Biosciences of California, Inc.

2024-05-08 Q1 2024 Earnings Release After hours
2024-05-09 05:00 pm Q1 2024 Earnings Call
2024-07-30 Q2 2024 Earnings Release (Projected)
2024-11-03 Q3 2024 Earnings Release (Projected)
2025-02-12 Q4 2024 Earnings Release (Projected)
2025-04-30 Q1 2025 Earnings Release (Projected)

Past events on Pacific Biosciences of California, Inc.

2024-03-12 10:15 am Barclays Global Healthcare Conference
2024-03-05 01:30 pm TD Cowen Health Care Conference
2024-02-15 05:00 pm Q4 2023 Earnings Call
2024-02-15 04:05 pm Q4 2023 Earnings Release
2024-01-10 04:30 pm JPMorgan Healthcare Conference
2023-11-28 03:00 pm Piper Sandler Healthcare Conference
2023-11-16 02:00 pm Canaccord Genuity MedTech Diagnostics and Digital Health and Services Forum
2023-10-30 04:30 pm Q3 2023 Earnings Call
2023-10-30 04:03 pm Q3 2023 Earnings Release
2023-09-12 12:55 pm Morgan Stanley Global Healthcare Conference
2023-08-16 07:00 pm UBS MedTech, Tools and Genomics Summit
2023-08-02 05:00 pm Q2 2023 Earnings Call
2023-08-02 04:06 pm Q2 2023 Earnings Release
2023-06-13 11:00 am Goldman Sachs Global Healthcare Conference
2023-06-01 02:30 pm Bernstein Strategic Decisions Conference
2023-05-24 12:00 pm Annual General Meeting
2023-05-10 12:20 pm Bank of America Healthcare Conference
2023-05-06 ABRF Annual Meeting
2023-05-02 04:30 pm Q1 2023 Earnings Call
2023-05-02 04:01 pm Q1 2023 Earnings Release

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Million USD
Released
Forecast
Spread
90,9
88,4
2.84%
78,9
76,5
3.07%
131
130
0.02%
128
128
0.06%
201
201
-0.01%

193

EBITDA
Million USD
Released
Forecast
Spread
-93,3
-101
7.6%
-98,0
-95,4
-2.66%
-203
-187
-8.65%
-297
-291
-2.11%
-315
-300
-4.82%

-266

EBIT
Million USD
Released
Forecast
Spread
-101
-108
6.65%
-104
-103
-1.66%
-210
-208
-1.06%
-307
-299
-2.75%
-334
-316
-5.98%

-286

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
-84,1
-109
23.08%
29,4
30,9
-4.89%
-275
-264
-4.03%
-314
-312
-0.82%
-318
-307
-3.52%

-279

Net income
Million USD
Released
Forecast
Spread
-84,1
-109
23.08%
29,4
30,7
-4.32%
-181
-177
-2.56%
-314
-312
-0.82%
-307
-298
-2.78%

-283

EPS
USD
Released
Forecast
Spread
-0,55
-0,72
23.23%
0,17
0,17
-1.92%
-0,89
-0,90
1.63%
-1,40
-1,39
-1%
-1,21
-1,18
-2.72%

-1,04

Announcement Date06/02/2010/02/2115/02/2216/02/2315/02/24-

Quarterly results

Fiscal PeriodDecember 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1
Net sales
Million USD
Released
Forecast
Spread
36,0
36,0
0.05%
33,2
32,8
1.08%
35,5
35,2
0.87%
32,3
35,4
-8.73%
27,4
27,3
0.24%
38,9
34,4
13.15%
47,6
39,9
19.19%
55,7
48,6
14.51%
58,4
58,3
0.08%

42,6


45,9


50,1


56,6


59,6

EBITDA
Million USD
Released
Forecast
Spread
-62,2
-57,3
-8.54%
-75,0
-63,5
-18.15%
-65,4
-71,5
8.51%
-72,0
-67,8
-6.34%
-84,3
-77,6
-8.68%
-88,3
-76,6
-15.29%
-71,1
-73,2
2.86%
-68,2
-74,7
8.72%
-77,7
-76,8
-1.16%

-73,4


-69,3


-65,5


-62,7


-63,0

EBIT
Million USD
Released
Forecast
Spread
-64,7
-58,9
-9.73%
-77,5
-67,4
-15.05%
-68,0
-74,0
8.13%
-74,6
-70,3
-6.21%
-87,1
-79,0
-10.18%
-91,3
-80,0
-14.02%
-73,2
-78,0
6.19%
-73,0
-76,3
4.27%
-87,5
-78,2
-11.94%

-76,6


-72,7


-70,0


-67,5


-67,1

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
-68,2
-62,4
-9.22%
-81,5
-71,1
-14.56%
-71,4
-77,8
8.26%
-77,0
-74,0
-4.07%
-84,4
-81,9
-3.07%
-88,0
-85,1
-3.38%
-69,8
-82,0
14.86%
-77,6
-101
23.46%
-82,7
-75,3
-9.89%

-76,4


-72,5


-69,0


-66,2


-66,3

Net income
Million USD
Released
Forecast
Spread
-69,3
-62,4
-11.1%
-81,5
-71,1
-14.56%
-71,4
-77,8
8.26%
-77,0
-74,2
-3.79%
-84,4
-82,0
-2.87%
-88,0
-85,3
-3.13%
-69,8
-82,0
14.86%
-66,9
-101
34.02%
-82,0
-75,3
-8.94%

-76,4


-72,5


-69,0


-66,2


-66,3

EPS
USD
Released
Forecast
Spread
-0,31
-0,28
-9.32%
-0,37
-0,32
-15.61%
-0,32
-0,34
5.4%
-0,34
-0,33
-2.51%
-0,37
-0,36
-2.45%
-0,36
-0,33
-8.6%
-0,28
-0,32
12.64%
-0,26
-0,35
24.72%
-0,31
-0,29
-7.83%

-0,28


-0,26


-0,25


-0,24


-0,24

Announcement Date15/02/2204/05/2203/08/2207/11/2216/02/2302/05/2302/08/2330/10/2315/02/24-----

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. PACB Stock
  4. P09 Stock
  5. Calendar Pacific Biosciences of California, Inc.